Feature | Â | Frequency N (%) | P-value | |
---|---|---|---|---|
 |  | Low (n = 68; 69.4) | High (n = 30; 30.6) |  |
Sex (n = 97) | Male | 42 (62.7) | 12 (40.0) | 0.0476 |
 | Female | 25 (37.3) | 18 (60.0) |  |
Age at diagnosis (yrs) | Median (min, max) | 65 (42–83) | 61 (35–84) | 0.914 |
Tumor size (cm) | Median (min, max) | 3 (1.2-6.5) | 3.3 (1.2-10) | 0.6526 |
pT classification (n = 97) | pT1-2 | 3 (4.5) | 7 (23.3) | 0.0089 |
 | pT3-4 | 64 (95.5) | 23 (76.7) |  |
Tumor grade (n = 98) | G1-2 | 8 (11.8) | 3 (10.0) | 1.0 |
 | G3 | 60 (88.2) | 27 (90.0) |  |
pN classification (n = 97) | pN0 | 12 (17.9) | 5 (16.7) | 1.0 |
 | pN1-2 | 55 (82.1) | 25 (83.3) |  |
pM classification (n = 97) | pM0 | 62 (92.5) | 27 (90.0) | 0.6996 |
 | pM1 | 5 (7.5) | 3 (10.0) |  |
Pn classification (n = 96) | Pn0 | 0 (0.0) | 1 (3.5) | 0.3021 |
 | Pn1 | 67 (100.0) | 28 (96.6) |  |
Lymphatic invasion (n = 97) | Negative | 13 (19.4) | 6 (200.) | 1.0 |
 | Positive | 54 (80.6) | 24 (80.0) |  |
Venous invasion (n = 97) | Negative | 53 (79.1) | 22 (73.3) | 0.6025 |
 | Positive | 14 (20.9) | 8 (26.7) |  |
R classification (n = 97) | R0 | 45 (67.2) | 22 (73.3) | 0.6382 |
 | R1 | 22 (32.8) | 8 (26.7) |  |
Adjuvant chemo (n = 89) | Untreated | 1 (1.6) | 2 (7.4) | 0.2174 |
 | Treated | 61 (98.4) | 25 (92.6) |  |
Tumor budding 10-in-10 | Low-grade | 16 (26.2) | 10 (33.3) | 0.6221 |
(n = 91) | High-grade | 45 (73.8) | 20 (66.7) | Â |
Intratumoral budding | Negative/Low | 26 (38.2) | 12 (41.4) | 0.8224 |
(n = 97) | Medium/High | 42 (61.8) | 17 (58.6) |  |
°Fisher’s Exact test |  |  |  |  |